Clinical Ageing Research Unit
The Clinical Ageing Research Unit (CARU) is a £5.5 million clinical research facility funded by the Wellcome Trust and Wolfson Foundation.
We opened in September 2008 and are located on the University’s Campus for Ageing and Vitality.
Our primary aim is to facilitate the development of early assessment and intervention strategies targeted at age-associated degenerative conditions.
We provide a high quality, patient-friendly environment for phase II-IV clinical studies in the older patient. We employ experienced research nurses with specific training in commonly used, relevant assessment instruments.
Clinical trials are supported by a high quality research infrastructure, embedded within the joint Acute Trust-University research system, with a study coordinator and data manager located on site.
The Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University were jointly awarded the NIHR Newcastle Biomedical Research Centre (BRC) status by the National Institute for Health Research. The NIHR Newcastle Biomedical Research Centre aims to improve the lives of the growing number of older people through translational research into ageing syndromes and long-term conditions. Research themes comprise:
- Parkinson’s Disease
- Other Neurodegenerative Diseases
- Liver Disease
- Musculoskeletal Disease
- Neuromuscular Disease
- Skin and Oral Disease
- And syndromes common to the older population, such as stroke and cardiovascular ageing, visual failure and diabetes.
CARU has a key role in delivering studies falling within these research themes.
Partners and funding
In conjunction with the NIHR Research Design Service North East, Newcastle University, NUTH and CNTW colleagues, the Clinical Ageing Research Unit (CARU) at Newcastle provides a ‘one stop shop’ for investigators planning, designing, conducting and analysing trials and other high quality clinical research studies.